Revisiting the hERG safety margin after 20 years of routine hERG screening
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference23 articles.
1. Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc;Bednar;American Journal of Cardiology,2002
2. A simple model to solve a complex drug toxicity problem;Dixit;Toxicological Research,2019
3. Scientific white paper on concentration-QTc modeling;Garnett;Journal of Pharmacokinetics and Pharmacodynamics,2018
4. An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation;Gintant;Pharmacology and Therapeutics,2011
5. Evidence for the hERG liability of antihistamines, antipsychotics, and anti-infective agents: A systematic literature review from the ARITMO project;Hazell;Journal of Clinical Pharmacology,2017
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer;Gastric Cancer;2024-08-27
2. Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions.;Journal of Pharmacological and Toxicological Methods;2024-07
3. The Efficacy, Effectiveness, and Efficiency of Integrated QTc Assessment: Rationalizing Approaches to New Drug Modalities;Clinical Pharmacology & Therapeutics;2024-02-21
4. Electrophysiological Changes in the Rabbit Ventricular Wedge and Human-Induced Pluripotent Stem-Cell Derived (IPSC) Cardiomyocytes Translate to Severe Arrhythmia Observed in a Canine Toxicology Study, Not Predicted by Standard In Vitro Ion Channel Assays;International Journal of Toxicology;2024-02-08
5. Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer;Frontiers in Oncology;2024-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3